MSTR Lost Year, Bitcoin Slump Tests Strategy's Bet
MicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
Which Retirement Index Funds Have The Smallest Fees
This comparison highlights retirement index funds with the smallest fees, helping you choose cost-efficient options for a brighter retirement.
27,211 articles
Late Amcor After Recent Rally: Should You Buy Now?
Amcor has quietly moved higher in recent months, offering a steady income play in a volatile market. In this guide, w...
Time Energy Transfer Growth: Is It Time to Buy ET?
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Still Buying Salesforce Stock: My Candid Holdback Revealed
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
Bill Gates Apologizes to Foundation Staff Over Epstein Ties
Bill Gates apologizes to foundation staff after renewed scrutiny of his ties to Jeffrey Epstein, triggering a broader...
World Economic Forum Head Resigns Over Epstein Ties
The world economic forum head Børge Brende resigned Thursday amid scrutiny over ties to Jeffrey Epstein. An independe...
Jack Dorsey’s Block Cuts 4,000 Jobs in AI Pivot
Block reveals a sweeping AI-focused restructuring, trimming about 40% of its workforce and triggering a strong after-...
Where Will Beyond Meat Stock Be in 2027 and Beyond?
The plant-based meat craze brought BYND into the spotlight, but the path forward is uncertain. This guide examines wh...
Most Influential Guns Modern: Market Signals for Investors
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
Euronet Stock Tanked This: A Bold $8 Million Bet in 2026
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status